Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 3
2000 3
2001 3
2002 5
2003 1
2004 2
2005 2
2006 2
2007 3
2008 11
2009 8
2010 7
2011 10
2012 9
2013 4
2014 3
2015 3
2016 4
2017 9
2018 3
2019 6
2020 4
2021 10
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants.
Spratt AN, Kannan SR, Woods LT, Weisman GA, Quinn TP, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Spratt AN, et al. Among authors: lorson cl. bioRxiv. 2021 Mar 24:2021.03.24.436850. doi: 10.1101/2021.03.24.436850. Preprint. bioRxiv. 2021. PMID: 33791700 Free PMC article.
Infectivity of SARS-CoV-2: there Is Something More than D614G?
Kannan SR, Spratt AN, Quinn TP, Heng X, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Kannan SR, et al. Among authors: lorson cl. J Neuroimmune Pharmacol. 2020 Dec;15(4):574-577. doi: 10.1007/s11481-020-09954-3. Epub 2020 Sep 15. J Neuroimmune Pharmacol. 2020. PMID: 32930936 Free PMC article. No abstract available.
Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors.
Acharya A, Pandey K, Thurman M, Klug E, Trivedi J, Lorson CL, Singh K, Byrareddy SN. Acharya A, et al. Among authors: lorson cl. bioRxiv. 2021 Apr 2:2021.04.02.438204. doi: 10.1101/2021.04.02.438204. Preprint. bioRxiv. 2021. PMID: 33821265 Free PMC article. Updated.
RNA-targeting approaches for neuromuscular diseases.
Le Roy F, Charton K, Lorson CL, Richard I. Le Roy F, et al. Among authors: lorson cl. Trends Mol Med. 2009 Dec;15(12):580-91. doi: 10.1016/j.molmed.2009.10.005. Epub 2009 Nov 10. Trends Mol Med. 2009. PMID: 19906562 Review.
109 results